Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Buy
60
JNJ Quote, Financials, Valuation and Earnings
Last price:
$202.60
Seasonality move
:
1.27%
Day range:
$204.99 - $207.02
52-week range:
$140.68 - $207.81
Dividend yield:
2.5%
P/E ratio:
19.82x
P/S ratio:
5.40x
P/B ratio:
6.24x
Volume:
8.4M
Avg. volume:
8.8M
1-year change:
34.77%
Market cap:
$494.7B
Revenue:
$88.8B
EPS (TTM):
$10.36
Analysts' Opinion
-
Consensus RatingJohnson & Johnson has received a consensus rating of Hold. The company's average rating is a Hold based on 9 Buy ratings, 11 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $202.54, Johnson & Johnson has an estimated downside of -1.36% from its current price of $205.33.
-
Price Target UpsideAccording to analysts, the highest upside price target is $230.00 representing 12.02% upside increase from its current price of $205.33.
Fair Value
-
According to the consensus of 20 analysts, Johnson & Johnson has -1.36% downside to fair value with a price target of $202.54 per share.
JNJ vs. S&P 500
-
Over the past 5 trading days, Johnson & Johnson has underperformed the S&P 500 by -0.66% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Johnson & Johnson does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Johnson & Johnson has grown year-over-year revenues for 9 quarters straight. In the most recent quarter Johnson & Johnson reported revenues of $24B.
Earnings Growth
-
Johnson & Johnson has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Johnson & Johnson reported earnings per share of $2.12.
Enterprise value:
521.9B
EV / Invested capital:
4.17x
Price / LTM sales:
5.40x
EV / EBIT:
21.96x
EV / Revenue:
5.66x
PEG ratio (5yr expected):
0.28x
EV / Free cash flow:
25.51x
Price / Operating cash flow:
24.33x
Enterprise value / EBITDA:
16.75x
Gross Profit (TTM):
$62.9B
Return On Assets:
13.39%
Net Income Margin (TTM):
27.26%
Return On Equity:
33.27%
Return On Invested Capital:
20.94%
Operating Margin:
29.64%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $83.7B | $87.7B | $92.1B | $22.5B | $24B | |
| Gross Profit | $58.2B | $60.2B | $62.9B | $15.5B | $16.7B | |
| Operating Income | $22.8B | $21.6B | $23.8B | $5.1B | $7.1B | |
| EBITDA | $30.1B | $28.9B | $31.2B | $7B | $8.9B | |
| Diluted EPS | $5.24 | $6.05 | $10.36 | $1.11 | $2.12 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $59.9B | $65.2B | $53.7B | $53.2B | $54.6B | |
| Total Assets | $179.2B | $175.1B | $166.1B | $178.3B | $192.8B | |
| Current Liabilities | $44.6B | $45.5B | $44.4B | $51.8B | $50.9B | |
| Total Liabilities | $109B | $100.5B | $94.8B | $108.1B | $113.5B | |
| Total Equity | $70.3B | $74.6B | $71.2B | $70.2B | $79.3B | |
| Total Debt | $33.9B | $27.6B | $26.1B | $31.3B | $39.4B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $20.3B | $25.1B | $24.2B | $8B | $9.2B | |
| Cash From Investing | -$2.3B | -$18.5B | -$20.4B | -$3.1B | -$542M | |
| Cash From Financing | -$9.5B | -$6.4B | -$5.5B | -$9.9B | -$8.9B | |
| Free Cash Flow | $15.7B | $19.5B | $20.5B | $5.7B | $8B | |
JNJ
Sector
Market Cap
$494.7B
$28.4M
Price % of 52-Week High
98.81%
50.35%
Dividend Yield
2.5%
0%
Shareholder Yield
3.08%
-1.32%
1-Year Price Total Return
34.77%
-22.19%
Beta (5-Year)
0.357
0.521
Dividend yield:
2.5%
Annualized payout:
$4.91
Payout ratio:
61.28%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$205.90
200-day SMA
Buy
Level
$169.84
Bollinger Bands (100)
Buy
Level
171.04 - 194.6
Chaikin Money Flow
Buy
Level
2.1B
20-day SMA
Buy
Level
$198.99
Relative Strength Index (RSI14)
Buy
Level
73.17
ADX Line
Buy
Level
38.96
Williams %R
Sell
Level
-17.2702
50-day SMA
Buy
Level
$192.49
MACD (12, 26)
Buy
Level
4.63
25-day Aroon Oscillator
Buy
Level
80
On Balance Volume
Neutral
Level
1B
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.0457)
Buy
CA Score
(Annual)
Level (-0.1681)
Buy
Beneish M-Score
(Annual)
Level (-2.7278)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-1.4297)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Stock Forecast FAQ
In the current month, JNJ has received 9 Buy ratings 11 Hold ratings, and 0 Sell ratings. The JNJ average analyst price target in the past 3 months is $202.54.
-
Where Will Johnson & Johnson Stock Be In 1 Year?
According to analysts, the consensus estimate is that Johnson & Johnson share price will drop to $202.54 per share over the next 12 months.
-
What Do Analysts Say About Johnson & Johnson?
Analysts are divided on their view about Johnson & Johnson share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Johnson & Johnson is a Sell and believe this share price will rise from its current level to $155.00.
-
What Is Johnson & Johnson's Price Target?
The price target for Johnson & Johnson over the next 1-year time period is forecast to be $202.54 according to 20 Wall Street analysts, 9 of them rate the stock a Buy, 0 rate the stock a Sell, and 11 analysts rate the stock a Hold.
-
Is JNJ A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Johnson & Johnson is a Hold. 11 of 20 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of JNJ?
You can purchase shares of Johnson & Johnson via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Johnson & Johnson shares.
-
What Is The Johnson & Johnson Share Price Today?
Johnson & Johnson was last trading at $202.60 per share. This represents the most recent stock quote for Johnson & Johnson. Yesterday, Johnson & Johnson closed at $205.33 per share.
-
How To Buy Johnson & Johnson Stock Online?
In order to purchase Johnson & Johnson stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get JNJ Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
JNJ
Sector
P/E ratio
19.82x
23.66x
PEG ratio
0.28x
-0.01x
P/B ratio
6.24x
1.84x
Price / LTM sales
5.40x
1.60x
Growth Metrics
JNJ
Sector
Revenue growth
6.77%
4.85%
Earnings growth
91.19%
11.15%
Revenue (5-year growth)
1.58%
6.45%
Earnings forecast
$2.76
-$0.20
Profitability
JNJ
Sector
Profitability FY 2024
$61B
$3.6M
Return on invested capital
20.94%
-30.98%
Return on assets
13.39%
-27.62%
Return on equity
33.27%
-36.69%
Earnings Date
Last Earnings Date
Oct
14
Next Earnings Date
Jan
21
Estimated Next Earnings Date
Jan
13
Balance Sheet
JNJ
Sector
Total cash
$18.6B
$27.2M
Short term investments
$417M
$25.7M
Total assets
$180.1B
$79.9M
Long term debt
$39.4B
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 61x
Buy
65
Is AAPL Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 38x
Buy
69
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Sell
47
PSTG alert for Dec 4
Pure Storage, Inc. [PSTG] is up 5.05% over the past day.
Sell
41
SMX alert for Dec 4
SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.
Sell
43
HY alert for Dec 4
Hyster-Yale, Inc. [HY] is up 1.92% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
